Literature DB >> 697431

Failure of low dose heparin to prevent pulmonary embolism after hip surgery or above the knee amputation.

J W Williams, E A Eikman, S H Greenberg, J C Hewitt, E Lopez-Cuenca, G P Jones, J A Madden.   

Abstract

In a randomized, double-blind trial, 5,000 USP units of sodium heparin or saline were give subcutaneously at least two hours before surgery and at 12 hour intervals thereafter to patients requiring total hip replacement, surgical correction of hip fracture, or major lower extremity amputation for vascular insufficiency. Lung perfusion scans were performed before surgery and at weekly intervals during the postoperative period. Pulmonary arteriograms were requested in patients developing new perfusion defects on serial scans. Two hundred twelve patient hospitalizations were analyzed. We diagnosed acute pulmonary embolism by serial lung perfusion scans or at autopsy in 37 patients. The incidence of pulmonary embolism in 40 patients with below the knee amputation was too low to warrant conclusions. The incidence of acute pulmonary embolism in 94 patients undergoing above the knee amputation was 25% in patients receiving heparin and 27% in patients receiving saline. The incidence of acute pulmonary embolism in 78 patients undergoing hip surgery was 13% in patients receiving heparin and 12% in patients receiving saline. We conclude that the regimen used had no significant effect on the incidence of acute pulmonary embolism in patients undergoing hip surgery or above the knee amputation.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 697431      PMCID: PMC1396839          DOI: 10.1097/00000658-197810000-00004

Source DB:  PubMed          Journal:  Ann Surg        ISSN: 0003-4932            Impact factor:   12.969


  22 in total

1.  Overdiagnosis and overtreatment of pulmonary embolism: the emperor may have no clothes.

Authors:  E D Robin
Journal:  Ann Intern Med       Date:  1977-12       Impact factor: 25.391

2.  Comparison of warfarin, low-molecular-weight dextran, aspirin, and subcutaneous heparin in prevention of venous thromboembolism following total hip replacement.

Authors:  W H Harris; E W Salzman; C Athanasoulis; A C Waltman; S Baum; R W DeSanctis
Journal:  J Bone Joint Surg Am       Date:  1974-12       Impact factor: 5.284

3.  Failure of low-dose heparin to prevent deep-vein thrombosis after hip-replacement arthroplasty.

Authors:  W G Hampson; F C Harris; H K Lucas; P H Roberts; I W McCall; P C Jackson; N L Powell; G E Staddon
Journal:  Lancet       Date:  1974-10-05       Impact factor: 79.321

4.  A double-blind trial of low doses of subcutaneous heparin in the prevention of deep-vein thrombosis after myocardial infarction.

Authors:  C Warlow; G Terry; A C Kenmure; A G Beattie; D Ogston; A S Douglas
Journal:  Lancet       Date:  1973-10-27       Impact factor: 79.321

5.  Efficacy of low doses of heparin in prevention of deep-vein thrombosis after major surgery. A double-blind, randomised trial.

Authors:  V V Kakkar; T Corrigan; J Spindler; D P Fossard; P T Flute; R Q Crellin; S Wessler; E T Yin
Journal:  Lancet       Date:  1972-07-15       Impact factor: 79.321

6.  Prevention of sudden cardiopulmonary arrest in the perioperative period with prophylactic heparin.

Authors:  J G Sharnoff
Journal:  Lancet       Date:  1969-08-09       Impact factor: 79.321

7.  125I fibrinogen and the prevention of venous thrombosis.

Authors:  M Hume; T X Kuriakose; L Zuch; R H Turner
Journal:  Arch Surg       Date:  1973-11

8.  Effect of intravenous dextran 70 and pneumatic leg compression on incidence of postoperative pulmonary embolism.

Authors:  N L Browse; G Clemenson; N T Bateman; J I Gaunt; D N Croft
Journal:  Br Med J       Date:  1976-11-27

9.  Prevention of fatal pulmonary thromboembolism by heparin prophylaxis after surgery for hip fractures.

Authors:  J G Sharnoff; R L Rosen; A H Sadler; G C Ibarra-Isunza
Journal:  J Bone Joint Surg Am       Date:  1976-10       Impact factor: 5.284

10.  Prevention of postoperative thromboembolism by dextran 40, low doses of heparin, or xantinol nicotinate.

Authors:  U F Gruber; F Duckert; R Fridrich; J Torhorst; J Rem
Journal:  Lancet       Date:  1977-01-29       Impact factor: 79.321

View more
  8 in total

1.  Venous thromboembolism in coronary artery surgery.

Authors:  N Briffa; S R Large
Journal:  Heart       Date:  1996-05       Impact factor: 5.994

2.  Prophylaxis of venous thromboembolism: analysis of cost effectiveness.

Authors:  E W Salzman; G C Davies
Journal:  Ann Surg       Date:  1980-02       Impact factor: 12.969

Review 3.  The pathogenesis and prevention of thromboembolic complications in patients undergoing total hip replacement.

Authors:  D K Potyk; H J Tabbarah
Journal:  J Gen Intern Med       Date:  1993-04       Impact factor: 5.128

4.  Asymptomatic pulmonary embolism. A common event in high risk patients.

Authors:  J W Williams; E A Eikman; S Greenberg
Journal:  Ann Surg       Date:  1982-03       Impact factor: 12.969

Review 5.  [Thrombosis prevention with heparin/dihydroergotamine versus heparin/Sintrom in Ender nailing of pertrochanteric fractures].

Authors:  G Schlag; T Gaudernak; H Pelinka; H Redl; H Kuderna; J Poigenfürst
Journal:  Unfallchirurgie       Date:  1988-02

6.  Primary prophylaxis for venous thromboembolism in people undergoing major amputation of the lower extremity.

Authors:  David Rb Herlihy; Matthew Thomas; Quoc H Tran; Vikram Puttaswamy
Journal:  Cochrane Database Syst Rev       Date:  2020-07-21

7.  Prevention of deep vein thrombosis with low molecular-weight heparin in patients undergoing total hip replacement. A randomized trial. The German Hip Arthroplasty Trial (GHAT) Group.

Authors: 
Journal:  Arch Orthop Trauma Surg       Date:  1992       Impact factor: 3.067

8.  All-Cause Mortality Amongst Patients Undergoing Above and Below Knee Amputation in a Regional Vascular Centre within 2014-2015.

Authors:  Gem Kennedy; K McGarry; G Bradley; D W Harkin
Journal:  Ulster Med J       Date:  2019-01-22
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.